$PHAR

Best Momentum Stocks to Buy for July 17th

PROK, ROKU and PHAR made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on July 17, 2025.

Original reporting
Zacks Commentary · Zacks Equity Research
Published Jul 17, 2025, 2:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 18, 2025, 12:03 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Best Momentum Stocks to Buy for July 17th — source image
Decision brief

The 30-second read

$PHARNeutralMed
01

Why it matters

While momentum stocks can offer short-term gains, they also carry higher volatility and risk of reversal.

02

Market read

The stocks identified are relevant for traders seeking short-term opportunities within the Technology and Life Sciences sectors.

03

What to watch

Potential upcoming earnings reports or sector news could significantly alter momentum and sentiment.

Timing: Short to medium term (next 1-2 weeks)

Background

The article highlights stocks with strong recent performance and positive momentum signals.

Company-level read

Ticker impact

$PHARNeutralMedium confidence
Context

Moderately relevant due to neutral sentiment and industry involvement in Life Sciences.

Expected impact

Minimal short-term price movement expected; long-term outlook remains uncertain.

Evidence & confidence

Neutral sentiment and lack of recent positive catalysts suggest limited short-term momentum.

$ROKUNeutralMedium confidence
Context

Highly relevant given its strong relevance score and position in Technology.

Expected impact

Potential moderate increase (~3-5%) over the next 1-2 weeks if momentum persists.

Evidence & confidence

Neutral sentiment indicates no immediate reversal, but technical momentum could support gains.

$PROKNeutralMedium confidence
Context

Most relevant among the listed stocks, with the highest relevance score.

Expected impact

Expected modest gains (~2-4%) over the near term, contingent on market conditions.

Evidence & confidence

Momentum and technical indicators support ongoing strength, but neutral sentiment warrants caution.

Market effects

Positive outlook for Technology and Life Sciences sectors due to momentum in key stocks.

Limited regional impact; primarily US-based stocks.

Moderate; reflects sector-specific momentum rather than broad market shifts.

Counterpoint

Neutral sentiment may indicate a lack of strong catalysts; stocks could stagnate or decline if broader market conditions worsen.

Key entities

  • Zacks Equity Research

    Provider of stock analysis and investment research.

Related articles

$PROKMed

PROKIDNEY CORP. (PROK): Results of Operations and Financial Condition

PROKIDNEY CORP. (PROK) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 prok-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 ProKidney Reports Second Quarter 2026 Financial Results and Business Highlights • Completed enrollment of patients contributing to the Phase 3 PROACT 1 accelerated approval efficacy analysis, positioning the Company for antic

$ROKUMed

Roku Credits Search, AI In Shareholder Letter To Revenue Increase

Roku said in a shareholder letter that it upgraded search and ad-tech, adding advanced AI to better interpret viewer queries. For the quarter ended June 30, advertising revenue rose 25% to $673 million and subscription revenue rose 26% to $548 million. Total revenue increased 21.6% to $1.35 billion, aided by the FIFA World Cup, and Roku cited DSP and API partner expansion.

$ROKUMed

Roku Q2 Ad Spend +25%, Subs Rise 26%

Roku reported Q2 results: advertising revenue rose 25% to $672.8 million and subscriptions rose 26% to $548.2 million. Total revenue grew 22% to $1.35 billion and gross profit increased 35% to $674 million, helped by higher-margin ad products. The article notes Fox Corp. agreed to buy Roku for $22 billion and cites Nielsen and estimates of combined ad revenue.

$ROKUMed

Roku Ad Spend Up 25%, Subscriptions Rise 26%

Roku reported quarterly gains, with advertising revenue up 25% to $672.8 million and subscriptions up 26% to $548.2 million, alongside total revenue up 22% to $1.35 billion and gross profit up 35% to $674 million, according to the company. Roku attributed ad growth to higher-margin ad products. Roku shares closed at $150.07, up 2%.

$ROKUMedAI 8/10

Roku Q2 Profit Jumps 1,464% With Fox Acquisition Looming

Roku reported Q2 profit of $164.2M, or $1.08/share, versus Wall Street expectations of 56 cents/share, and revenue of $1.35B versus $1.3B expected. Results were driven by higher subscription and advertising revenues and profitability. Roku shares rose slightly after-hours. The company’s pending $22B Fox acquisition is expected to close in H1 2027.